Abbott Laboratories (ABT) was upgraded today by Deutsche Bank (DB) from hold to buy with a price target of $70, as the firm believes that the recent split will be beneficial to the share price. Shares are higher by about 1.4 percent. E*Trade (ETFC) was upgraded today by Wells Fargo (WFC) from market perform to ...
FEEDS
